A good MD Pharmacology thesis in an Indian teaching hospital answers a question the department can actually measure: how drugs are prescribed, what harm they cause, what they cost, or how a compound behaves in a validated animal model. Prescription audits, active surveillance for adverse drug reactions, cost comparisons of common treatments and short experimental studies all fit comfortably within the residency, provided ethics approvals and clinical collaborators are arranged early.

The catalogue covers Drug Utilisation, Adverse Drug Reactions, Clinical Trials, Experimental Pharmacology, Pharmacoeconomics, Rational Use & Behaviour, Therapeutic Drug Monitoring and Antimicrobial Stewardship. Titles range from rodent models of ulcer, arthritis and cognition to pharmacovigilance KAP surveys, medication adherence studies and pre-post educational interventions. Objectives or a full synopsis can be bought for any title.

1What the MD Pharmacology catalogue covers

Our thesis-title catalogue, shared with our sister site medicalthesistopic.in, currently lists 228 MD Pharmacology titles. The newest ones are based on PubMed literature published in 2024–2026. Titles by subject area (top 10):

Subject areaTitles
Drug Utilisation34
Adverse Drug Reactions30
Clinical Trials28
Experimental Pharmacology22
Pharmacoeconomics21
Rational Use & Behaviour21
Therapeutic Drug Monitoring17
Antimicrobial Stewardship16
Medication Safety14
Pharmacogenomics13

Most common study designs: prospective observational study (89), randomised comparative trial (25), experimental animal study (22), pre-post interventional study (17), cross-sectional study (15), cross-sectional questionnaire-based study (14). Each title already names its study design, so you can see at a glance whether it suits your department's patient load and your timeline.

250 recent MD Pharmacology thesis titles

These 50 titles are free to read. Discuss any of them with your guide before you commit; check that it has not already been taken up in your department.

  1. 001

    Association of HLA-B*15:02 with carbamazepine-induced cutaneous adverse drug reactions

    PharmacogenomicsProspective observational studyProspective Study
  2. 002

    Association of TPMT polymorphism with azathioprine-induced myelotoxicity

    PharmacogenomicsProspective observational studyProspective Study
  3. 003

    Association of OCT1 gene polymorphism with glycaemic response to metformin in type 2 diabetes mellitus

    PharmacogenomicsProspective observational studyProspective Study
  4. 004

    Association of CYP2C9 polymorphism with phenytoin serum levels and toxicity in patients with epilepsy

    PharmacogenomicsProspective observational studyProspective Study
  5. 005

    Association of NAT2 acetylator status with anti-tubercular drug-induced hepatotoxicity

    PharmacogenomicsProspective observational studyProspective Study
  6. 006

    Association of SLCO1B1 polymorphism with statin-induced myopathy

    PharmacogenomicsProspective observational studyProspective Study
  7. 007

    Inhaler technique and its determinants in patients with bronchial asthma and COPD

    Rational Use & BehaviourCross-sectional analytical studyCross-sectional Study
  8. 008

    Impact of mobile phone reminders on medication adherence in patients with hypertension

    Rational Use & BehaviourRandomised controlled trialInterventional Study
  9. 009

    Use of complementary and alternative medicines among patients with chronic diseases and disclosure to physicians

    Rational Use & BehaviourCross-sectional questionnaire-based studyCross-sectional Study
  10. 010

    Knowledge and practice of safe disposal of unused medicines among patients attending outpatient departments

    Rational Use & BehaviourCross-sectional questionnaire-based studyKAP Study
  11. 011

    Medication adherence in patients with epilepsy and its association with seizure control

    Rational Use & BehaviourCross-sectional analytical studyCross-sectional Study
  12. 012

    Self-medication with antibiotics among the general public and associated factors

    Rational Use & BehaviourCross-sectional questionnaire-based studyCross-sectional Study
  13. 013

    Medication adherence and its determinants in patients with type 2 diabetes mellitus using the MARS-5 scale

    Rational Use & BehaviourCross-sectional questionnaire-based studyCross-sectional Study
  14. 014

    Knowledge, attitude and practice regarding pharmacovigilance among nursing staff and the effect of an educational intervention

    Rational Use & BehaviourPre-post interventional studyKAP Study
  15. 015

    Evaluation of the neuroprotective activity of a test drug in a rat model of cerebral ischaemia-reperfusion injury

    Experimental PharmacologyExperimental animal studyExperimental Study
  16. 016

    Evaluation of the antidepressant activity of metformin in rodent models of depression

    Experimental PharmacologyExperimental animal studyExperimental Study
  17. 017

    Evaluation of the anti-arthritic activity of a test drug in Freund's adjuvant-induced arthritis in rats

    Experimental PharmacologyExperimental animal studyExperimental Study
  18. 018

    Evaluation of the antihyperlipidaemic effect of a herbal extract in high-fat diet-fed rats

    Experimental PharmacologyExperimental animal studyExperimental Study
  19. 019

    Evaluation of the nootropic activity of a test drug in scopolamine-induced amnesia in mice

    Experimental PharmacologyExperimental animal studyExperimental Study
  20. 020

    Evaluation of the antiulcer activity of a herbal extract in pylorus ligation and ethanol-induced ulcer models in rats

    Experimental PharmacologyExperimental animal studyExperimental Study
  21. 021

    Evaluation of the cardioprotective effect of a test drug against isoproterenol-induced myocardial injury in rats

    Experimental PharmacologyExperimental animal studyExperimental Study
  22. 022

    Evaluation of the nephroprotective activity of a plant extract against gentamicin-induced nephrotoxicity in rats

    Experimental PharmacologyExperimental animal studyExperimental Study
  23. 023

    Comparison of fixed-dose combination of telmisartan and chlorthalidone versus telmisartan and amlodipine in stage 2 hypertension

    Clinical TrialsRandomised comparative trialComparative Study
  24. 024

    Efficacy of montelukast versus levocetirizine in allergic rhinitis: a randomised comparative study

    Clinical TrialsRandomised comparative trialComparative Study
  25. 025

    Comparison of saroglitazar versus vitamin E in patients with non-alcoholic fatty liver disease

    Clinical TrialsRandomised comparative trialComparative Study
  26. 026

    Comparison of topical tacrolimus versus clobetasol in localised vitiligo

    Clinical TrialsRandomised comparative trialComparative Study
  27. 027

    Comparison of mirtazapine versus escitalopram in major depressive disorder with insomnia

    Clinical TrialsRandomised comparative trialComparative Study
  28. 028

    Efficacy of oral iron versus intravenous ferric carboxymaltose in iron deficiency anaemia in pregnancy

    Clinical TrialsRandomised comparative trialComparative Study
  29. 029

    Comparison of teneligliptin versus vildagliptin as add-on to metformin in type 2 diabetes mellitus

    Clinical TrialsRandomised comparative trialComparative Study
  30. 030

    Efficacy and safety of vonoprazan versus pantoprazole in patients with erosive oesophagitis

    Clinical TrialsRandomised comparative trialComparative Study
  31. 031

    Comparison of chlorthalidone versus hydrochlorothiazide in patients with essential hypertension

    Clinical TrialsRandomised comparative trialComparative Study
  32. 032

    Comparison of efficacy and safety of empagliflozin versus dapagliflozin as add-on therapy in type 2 diabetes mellitus

    Clinical TrialsRandomised comparative trialComparative Study
  33. 033

    Plasma voriconazole trough levels and their correlation with efficacy and toxicity in invasive fungal infections

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  34. 034

    Serum levetiracetam levels in patients with epilepsy and their correlation with dose and seizure control

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  35. 035

    Cyclosporine trough levels and their correlation with graft function in renal transplant recipients

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  36. 036

    Serum valproate levels in patients with bipolar disorder and their correlation with clinical response

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  37. 037

    Amikacin peak and trough levels in critically ill patients and their correlation with nephrotoxicity

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  38. 038

    Therapeutic drug monitoring of carbamazepine in patients with epilepsy and its correlation with seizure control

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  39. 039

    Serum digoxin levels and their correlation with toxicity in patients with heart failure

    Therapeutic Drug MonitoringProspective observational studyProspective Study
  40. 040

    Cost of illness of patients with rheumatoid arthritis on conventional synthetic DMARDs

    PharmacoeconomicsCross-sectional studyPharmacoeconomic Study
  41. 041

    Cost-minimisation analysis of biosimilar versus innovator trastuzumab in carcinoma breast

    PharmacoeconomicsRetrospective record-based studyPharmacoeconomic Study
  42. 042

    Cost of managing adverse drug reactions in hospitalised patients

    PharmacoeconomicsProspective observational studyPharmacoeconomic Study
  43. 043

    Cost variation analysis of antiepileptic drugs available in the Indian market

    PharmacoeconomicsCross-sectional cost analysisPharmacoeconomic Study
  44. 044

    Out-of-pocket expenditure on medicines in patients with chronic diseases attending a tertiary care hospital

    PharmacoeconomicsCross-sectional studyPharmacoeconomic Study
  45. 045

    Cost-effectiveness analysis of insulin glargine versus NPH insulin in type 2 diabetes mellitus

    PharmacoeconomicsProspective observational studyPharmacoeconomic Study
  46. 046

    Cost of illness of drug-resistant tuberculosis from the patient perspective

    PharmacoeconomicsProspective observational studyPharmacoeconomic Study
  47. 047

    Cost variation analysis of oral anticancer drugs available in the Indian market

    PharmacoeconomicsCross-sectional cost analysisPharmacoeconomic Study
  48. 048

    Cost analysis and drug utilisation pattern in patients with type 2 diabetes mellitus attending the outpatient department

    PharmacoeconomicsCross-sectional cost analysisPharmacoeconomic Study
  49. 049

    Drug-induced QT prolongation in hospitalised patients receiving QT-prolonging drugs

    Adverse Drug ReactionsProspective observational studyPharmacovigilance Study
  50. 050

    Trends in spontaneous adverse drug reaction reporting at a newly established ADR monitoring centre over two years

    Adverse Drug ReactionsRetrospective record-based studyPharmacovigilance Study

3Download MD Pharmacology titles in Excel (β‚Ή1 per title)

Want more than these 50? Download an Excel of the newest titles: latest 100 for β‚Ή100, latest 500 for β‚Ή500, or all 228 titles at β‚Ή1 each. Or search a keyword (for example a disease or test) and pay only for the titles found. Pay by UPI, QR or card; the Excel downloads instantly.

πŸ“₯ MD Pharmacology Titles in Excel Β· β‚Ή1 per title

100 titles = β‚Ή100. Secure checkout (UPI / QR / card) on our sister site medicalthesistopic.in; the Excel downloads instantly.

1 Β· Speciality package (newest first)

2 Β· Or search a keyword

Or browse free titles by speciality β†’

4Objectives and synopsis for any title

Liked a title? Each one has two optional paid add-ons on medicalthesistopic.in, paid separately there:

  • Objectives (β‚Ή50): research question, aim, primary and secondary objectives, hypothesis and outcome measures for that exact title.
  • Full Plan / Synopsis (β‚Ή500): a complete synopsis draft for that title, from introduction and review-of-literature search plan to sample size working, methodology and statistical plan.

Use the buttons under each title above; they open that title on medicalthesistopic.in. Treat the output as a first draft to edit with your guide, and read how to write aims and objectives before you finalise yours.

5Tips for choosing a MD Pharmacology topic

  • Animal studies need Institutional Animal Ethics Committee clearance and a registered animal house before work starts; apply early, because approval cycles and animal procurement often delay experimental theses by months.
  • Prescription audits are cheap and quick, but use the WHO/INRUD core prescribing indicators and a clear sampling frame so your results are comparable with published Indian audits rather than a loose descriptive count.
  • For ADR studies, decide upfront how causality and severity will be graded; the WHO-UMC causality scale, Naranjo algorithm and Hartwig and Siegel severity scale are widely accepted, and reporting through PvPI adds credibility.
  • Therapeutic drug monitoring and clinical trial titles depend on assay availability and clinical collaborators; confirm that the laboratory can run the drug levels and that the treating department will recruit patients before you commit.

For the general checklist (patient load, timeline, cost, ethics), see how to choose an MD/MS thesis topic. Every titles page for other specialities is listed on thesis topics by speciality.

6Need help with your thesis?

PubMedico's team helps MD Pharmacology residents with synopsis writing, sample size, statistics and the final thesis draft. WhatsApp +91 78787 33004 for a free thesis guidance.

❓ Frequently Asked Questions

Quick answers to common questions on this topic

Is an animal study or a clinical study better for an MD Pharmacology thesis?+

Both are accepted. Animal studies give tight control and clear endpoints but need animal ethics approval, a functioning animal house and a reliable supply of drugs and reagents. Clinical studies such as prescription audits, ADR surveillance or adherence surveys depend on cooperation from clinical departments. Choose the option for which your department has the infrastructure and experienced guides.

Can a pharmacology resident run a clinical trial as a thesis?+

Yes, usually as a small randomised comparative trial of already approved drugs done with a clinical department. It needs institutional ethics committee approval, registration with the Clinical Trials Registry of India before enrolment, written informed consent and a clearly defined primary outcome. Trials of new investigational drugs are rarely feasible within a thesis.

What makes a pharmacoeconomics thesis feasible?+

Pick a common condition with two or more treatment options used in your hospital, then compare cost per patient or cost per outcome from the hospital or patient perspective. Costs can be taken from drug price lists and hospital records. Keep the analysis simple, such as cost-minimisation or cost-effectiveness, and state the perspective and time horizon clearly.

Can I use these MD Pharmacology titles directly as my thesis title?+

Use them as starting points. Discuss the title with your guide, check that it fits your department's patients and facilities, check it has not already been done at your institution, and adjust the wording before you submit it to your ethics committee.